Can over-the-counter (OTC) antidiarrheal medications be taken by someone with ulcerative colitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Individuals with colitis should avoid taking over-the-counter antidiarrheals unless specifically advised by their healthcare provider. This is because medications like loperamide (Imodium), bismuth subsalicylate (Pepto-Bismol), and diphenoxylate-atropine (Lomotil) can potentially worsen colitis by slowing intestinal motility, which may lead to toxic megacolon—a dangerous complication where harmful bacteria and toxins become trapped in the colon 1.

Key Considerations

  • The use of antimotility drugs, such as loperamide, is generally not recommended in patients with suspected or proven cases of inflammatory diarrhea or diarrhea with fever, as it may increase the risk of toxic megacolon 1.
  • Instead of self-medicating, patients with colitis should contact their gastroenterologist when experiencing diarrhea flares, as the appropriate treatment typically involves addressing the underlying inflammation with prescription medications such as corticosteroids, immunomodulators, or biologics 1.
  • During mild flares, staying hydrated, following a low-residue diet, and using prescribed medications are safer approaches than OTC antidiarrheals.

Treatment Options

  • The American Gastroenterological Association (AGA) recommends using infliximab, adalimumab, golimumab, vedolizumab, tofacitinib, or ustekinumab for the induction and maintenance of remission in adult outpatients with moderate to severe ulcerative colitis 1.
  • The choice of treatment should be individualized based on the patient's condition severity, overall health status, and preferences.

Important Reminders

  • Patients with colitis should always consult their healthcare provider before taking any medication, including over-the-counter antidiarrheals.
  • If a healthcare provider does recommend an antidiarrheal, they will provide specific instructions regarding dosage and duration based on the individual's condition severity and overall health status.

From the Research

Antidiarrheal Use in Colitis

  • The use of over-the-counter antidiarrheals in patients with colitis is a complex issue, and the decision to use them should be made on a case-by-case basis 2.
  • In patients with microscopic colitis, antidiarrheals such as loperamide may be used as the initial choice for mild symptoms 2.
  • However, in patients with severe colitis or toxic megacolon, medical management is crucial, and the use of antidiarrheals may not be sufficient 3, 4, 5.
  • In fact, the primary focus in managing severe colitis and toxic megacolon is on medical management, with surgical intervention considered only when necessary 4, 5.

Considerations for Antidiarrheal Use

  • The type and severity of colitis, as well as the patient's overall health, should be taken into account when considering the use of antidiarrheals 2, 6.
  • Patients with ulcerative colitis, for example, may require more aggressive treatment, including immunomodulator and/or biologic therapies, to manage their symptoms 6.
  • In contrast, patients with microscopic colitis may be able to manage their symptoms with antidiarrheals and other supportive measures 2.

Important Notes

  • The use of antidiarrheals in patients with colitis should be guided by a healthcare professional, as the decision to use them depends on various factors, including the type and severity of colitis, as well as the patient's overall health 2, 6.
  • Patients with colitis should be closely monitored for any changes in their symptoms or condition, and adjustments to their treatment plan should be made as needed 3, 4, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Microscopic Colitis: A Concise Review for Clinicians.

Mayo Clinic proceedings, 2021

Research

Toxic megacolon associated Clostridium difficile colitis.

World journal of gastrointestinal endoscopy, 2010

Research

Management of Severe Colitis and Toxic Megacolon.

Clinics in colon and rectal surgery, 2024

Research

Toxic Megacolon: Background, Pathophysiology, Management Challenges and Solutions.

Clinical and experimental gastroenterology, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.